6336 related articles for article (PubMed ID: 2921610)
21. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
22. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
Lai P; Rabinowich H; Crowley-Nowick PA; Bell MC; Mantovani G; Whiteside TL
Clin Cancer Res; 1996 Jan; 2(1):161-73. PubMed ID: 9816103
[TBL] [Abstract][Full Text] [Related]
23. Cimetidine reduces impairment of cellular immunity after transcatheter arterial embolization in patients with hepatocellular carcinoma.
Nishiguchi S; Tamori A; Shiomi S; Enomoto M; Tatsumi N; Koh N; Habu D; Sakaguchi H; Takeda T; Seki S; Nakamura K; Kubo S; Kinoshita H
Hepatogastroenterology; 2003; 50(50):460-2. PubMed ID: 12749247
[TBL] [Abstract][Full Text] [Related]
24. Natural killer cytolytic activity is associated with the expression of killer cell immunoglobulin-like receptors on peripheral lymphocytes in human.
Kogure T; Mantani N; Sakai S; Shimada Y; Tamura J; Terasawa K
Mediators Inflamm; 2003 Apr; 12(2):117-21. PubMed ID: 12775362
[TBL] [Abstract][Full Text] [Related]
25. [The effect of cimetidine mainly increases CD4+ cells of peripheral blood T lymphocytes].
Asakage M; Tsuno NH; Kitayama J; Yamada J; Tsuchiya T; Yoneyama S; Takahashi K; Nagawa H
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1576-7. PubMed ID: 16315874
[TBL] [Abstract][Full Text] [Related]
26. [Long-term immunological study on postoperative adjuvant treatment with interferon-gamma in patients with renal cell carcinoma who underwent nephrectomy].
Miura H; Arai H; Matsuoka A; Yazawa K; Satoh E; Nishimura K; Honda M; Fujioka H
Hinyokika Kiyo; 1999 Feb; 45(2):79-83. PubMed ID: 10212778
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
[TBL] [Abstract][Full Text] [Related]
28. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
Uchida A; Kolb R; Micksche M
J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
[TBL] [Abstract][Full Text] [Related]
29. Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores decreased monocyte HLA-DR expression after cardiopulmonary bypass.
Börgermann J; Friedrich I; Scheubel R; Kuss O; Lendemans S; Silber RE; Kreuzfelder E; Flohé S
Thorac Cardiovasc Surg; 2007 Feb; 55(1):24-31. PubMed ID: 17285470
[TBL] [Abstract][Full Text] [Related]
30. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.
Guillot B; Portalès P; Thanh AD; Merlet S; Dereure O; Clot J; Corbeau P
Br J Dermatol; 2005 Apr; 152(4):690-6. PubMed ID: 15840100
[TBL] [Abstract][Full Text] [Related]
31. [Cytolytic activity of mononuclear cells, T-lymphocytes and monocytes of the peripheral blood in patients with lung cancer].
Speranskiĭ DL; Blokhina NG; Bykovskaia SN; Kupriianova TA
Biull Eksp Biol Med; 1988 Jul; 106(7):68-70. PubMed ID: 3261176
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of coumarin and cimetidine in patients with metastatic renal cell carcinoma.
Dexeus FH; Logothetis CJ; Sella A; Fitz K; Amato R; Reuben JM; Dozier N
J Clin Oncol; 1990 Feb; 8(2):325-9. PubMed ID: 2137163
[TBL] [Abstract][Full Text] [Related]
33. Treatment of metastatic renal cell carcinoma with coumarin (1,2-benzopyrone) and cimetidine: a pilot study.
Marshall ME; Mendelsohn L; Butler K; Riley L; Cantrell J; Wiseman C; Taylor R; Macdonald JS
J Clin Oncol; 1987 Jun; 5(6):862-6. PubMed ID: 3585442
[TBL] [Abstract][Full Text] [Related]
34. Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial.
Lin CY; Bai DJ; Yuan HY; Wang K; Yang GL; Hu MB; Wu ZQ; Li Y
World J Gastroenterol; 2004 Jan; 10(1):136-42. PubMed ID: 14695785
[TBL] [Abstract][Full Text] [Related]
35. An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin.
Marshall ME; Mohler JL; Edmonds K; Williams B; Butler K; Ryles M; Weiss L; Urban D; Bueschen A; Markiewicz M
J Cancer Res Clin Oncol; 1994; 120 Suppl():S39-42. PubMed ID: 8132703
[TBL] [Abstract][Full Text] [Related]
36. Treatment of advanced malignant melanoma with coumarin and cimetidine: a pilot study.
Marshall ME; Butler K; Cantrell J; Wiseman C; Mendelsohn L
Cancer Chemother Pharmacol; 1989; 24(1):65-6. PubMed ID: 2720893
[TBL] [Abstract][Full Text] [Related]
37. Combined treatment of advanced malignant melanoma with coumarin and cimetidine. A phase II study.
Pedersen L; Rose C; Langvad E
Cancer Immunol Immunother; 1987; 24(2):178-9. PubMed ID: 3829053
[TBL] [Abstract][Full Text] [Related]
38. Treatment of human solid malignancies with autologous activated lymphocytes and cimetidine: a phase II trial of the cancer biotherapy research group.
Dillman RO; Soori G; DePriest C; Nayak SK; Beutel LD; Schiltz PM; de Leon C; O'Connor AA
Cancer Biother Radiopharm; 2003 Oct; 18(5):727-33. PubMed ID: 14629821
[TBL] [Abstract][Full Text] [Related]
39. Cimetidine in malignant melanoma.
Timm EG; Rozek SL
DICP; 1989 Sep; 23(9):689-91. PubMed ID: 2800583
[No Abstract] [Full Text] [Related]
40. Cimetidine modulates natural killer cell function of patients with chronic lymphocytic leukemia.
Allen JI; Syropoulos HJ; Grant B; Eagon JC; Kay NE
J Lab Clin Med; 1987 Apr; 109(4):396-401. PubMed ID: 3493314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
